Pharmacist-Led Care Expands the Value of Integrated Pharmacy Networks

Integrated pharmacy network services in Latin America are seeing stronger demand as policymakers and healthcare organizations reassess the role of pharmacists in primary care. The market is no longer focused only on dispensing and drug-cost administration. It is increasingly connected to adherence programs, minor ailment support, hypertension care and pharmacist-led interventions.

PAHO’s HEARTS Pharmacy framework describes an effort to integrate pharmacists into primary health care for hypertension and cardiovascular disease risk management. The paper says HEARTS in the Americas could, by 2026, surpass 17,000 participating primary health care centers and reach more than 10 million people receiving treatment. It also notes that pharmacy integration remains limited by structural barriers and policy gaps.

This is important because pharmacies tend to be more easily accessible compared to the clinic. Patients will go to pharmacies first to obtain refills or advice, even before going for professional treatment. It is through an integrated network service that such visits can be organized to be part of approved care pathways.

According to the study that was done recently concerning community pharmacies in Central America, there is a need for the development of protocols in relation to how the pharmacies interact with patients. The article says evidence from Latin American healthcare networks shows that minor ailment consultations in pharmacies require significant clinical decision-making and that regulatory compliance affects the appropriateness and safety of recommendations.

This is an opportunity for integrated pharmacy networks to provide more services. They can be involved in the training of pharmacists, referrals, medication therapy management and monitoring adherence and reporting to the health plans or care teams. The pharmacy will be acting as a managed care access point.

Pharmacy benefit management services are already moving toward this broader role. Market Research Future’s South America PBM services report covers claims management, formulary management, drug utilization review and medication therapy management across pharmacies, health plans, employers and public-sector users. The report projects a 6.14 percent CAGR from 2025 to 2035.

Medication therapy management is particularly crucial for patients suffering from aging and chronic conditions. A patient using various medications could be subject to drug duplication, contraindications, and forgotten refills. Medication therapy review by the pharmacist could prevent harm, as it is linked to reimbursement information and clinical guidelines.

The challenge is the professional scope. Pharmacy practice rules differ across Latin America, and not every country allows the same level of pharmacist intervention. Network providers must design services that comply with local rules while still encouraging safer medication use.

Reimbursement is another barrier. A pharmacist's time has value, but many systems still pay mainly for products rather than services. Integrated networks need payment models that recognize counseling, adherence support and clinical screening when these services improve care.

The next phase of pharmacy network development will likely favor providers that combine dispensing access with structured pharmacist involvement. The strongest networks will not be judged only by the number of locations.

Integrated pharmacy network services in Latin America are becoming pharmacist-enabled care systems. Their value will be measured by whether they help patients use medicines more safely while supporting payers, providers and public health programs with better medication-management data.